Loa loa: Difference between revisions

From IDWiki
Loa loa
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
No edit summary
Line 1: Line 1:
==Background==
==Background==
===Epidemiology===
===Epidemiology===

* Transmitted by ''[[Chrysops silacea]]'' and ''[[Chrysops dimidiata]]'' flies
*Transmitted by ''[[Chrysops silacea]]'' and ''[[Chrysops dimidiata]]'' flies
**Day biting flies, more common in rainy season and in rain forests
**Attracted by fires and to rubber plantations
*Present in West and Central Africa, primarily in Equatorial Guinea, Gabon, Cameroon, Central African Republic, Congo (Brazzaville), DRC, Nigeria, Chad, Sudan, Angola, Ethiopia


==Clinical Manifestations==
==Clinical Manifestations==

* Often asymptomatic
*Often asymptomatic
* Most common symptom is '''Calabar swellings''', a 10- to 20-cm painful, itchy subcutaneous swelling caused by migration of the adult worms
*Most common symptom is '''Calabar swellings''', a 10- to 20-cm painful, itchy subcutaneous swelling caused by migration of the adult worms
** The lesions are essentially angioedema in response to the worm
**The lesions are essentially angioedema in response to the worm
* Worms can also migrate to the conjunctiva, where they are visible
*Worms can also migrate to the conjunctiva, where they are visible
* Infection can be complicated by [[Causes::hematuria]] and [[Causes::proteinuria]], as well as as [[Causes::encephalitis]], precipitated by treatment during high-level microfilaremia
*Infection can be complicated by [[Causes::hematuria]] and [[Causes::proteinuria]]

=== Complications of Treatment ===

* Treatment with antiparasitics may cause an increase in symptoms such as Calabar swellings or pruritis
* With treatment of high-level parasitemia, can cause fatal encephalopathy

== Diagnosis ==

* Demonatration of microfilaria on Giemsa-stained blood film collected during daytime (10 am to 2 pm)
** Also provides quantification of microfilarial burden


==Management==
==Management==

* Must rule out high-level microfilaremia (>2500 microfilariae/mL) before considering medical treatment, due to the risk of encephalitis
*Not all infections require treatment
*Before treatment
**Must rule out high-level microfilaremia (>2500-8000 microfilariae/mL) before considering medical treatment, due to the risk of encephalopathy
**Rule out [[Onchocerca volvulus]] coinfection, as treatment with DEC can lead to blindness or exacerbation of skin disease
*If microfilaremia <8000 MF/mL
**First-line treatment is [[diethylcarbamazine]] 8-10 mg/kg/day po divided tid for 21 days
***Kills both the adult worms and microfilaria
**After failing 2 rounds of DEC, [[albendazole]] 200 mg bid for 21 days
*If microfilaremia ≥8000 MF/mL, either:
**[[Albendazole]] as above to decrease levels below 8000, followed by DEC as above
**Apheresis to decrease levels below 8000, followed by DEC as above
*Can consider concomitant [[antihistamines]] or [[corticosteroids]] during the first week of treatment to decrease symptoms associated with treatment


{{DISPLAYTITLE:''Loa loa''}}
{{DISPLAYTITLE:''Loa loa''}}

Revision as of 21:44, 11 September 2020

Background

Epidemiology

  • Transmitted by Chrysops silacea and Chrysops dimidiata flies
    • Day biting flies, more common in rainy season and in rain forests
    • Attracted by fires and to rubber plantations
  • Present in West and Central Africa, primarily in Equatorial Guinea, Gabon, Cameroon, Central African Republic, Congo (Brazzaville), DRC, Nigeria, Chad, Sudan, Angola, Ethiopia

Clinical Manifestations

  • Often asymptomatic
  • Most common symptom is Calabar swellings, a 10- to 20-cm painful, itchy subcutaneous swelling caused by migration of the adult worms
    • The lesions are essentially angioedema in response to the worm
  • Worms can also migrate to the conjunctiva, where they are visible
  • Infection can be complicated by hematuria and proteinuria

Complications of Treatment

  • Treatment with antiparasitics may cause an increase in symptoms such as Calabar swellings or pruritis
  • With treatment of high-level parasitemia, can cause fatal encephalopathy

Diagnosis

  • Demonatration of microfilaria on Giemsa-stained blood film collected during daytime (10 am to 2 pm)
    • Also provides quantification of microfilarial burden

Management

  • Not all infections require treatment
  • Before treatment
    • Must rule out high-level microfilaremia (>2500-8000 microfilariae/mL) before considering medical treatment, due to the risk of encephalopathy
    • Rule out Onchocerca volvulus coinfection, as treatment with DEC can lead to blindness or exacerbation of skin disease
  • If microfilaremia <8000 MF/mL
    • First-line treatment is diethylcarbamazine 8-10 mg/kg/day po divided tid for 21 days
      • Kills both the adult worms and microfilaria
    • After failing 2 rounds of DEC, albendazole 200 mg bid for 21 days
  • If microfilaremia ≥8000 MF/mL, either:
    • Albendazole as above to decrease levels below 8000, followed by DEC as above
    • Apheresis to decrease levels below 8000, followed by DEC as above
  • Can consider concomitant antihistamines or corticosteroids during the first week of treatment to decrease symptoms associated with treatment